|
Aurobindo Pharma Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
69411.60 Cr.
|
P/BV
|
2.13
|
Book Value (Rs.)
|
562.21
|
|
52 Week High/Low (Rs.)
|
1356/1010
|
FV/ML
|
1/1
|
P/E(X)
|
19.91
|
|
Bookclosure
|
08/08/2025
|
EPS (Rs.)
|
60.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 16028.73 | 16274.27 | 15103.86 | 15060.52 | 13941.35 |
| Other Operating Income | 125.11 | 86.37 | 259.23 | -128.59 | 128.59 |
| Total Income From Operations | 16153.84 | 16360.64 | 15363.09 | 14931.93 | 14069.94 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 5044.96 | 5528.25 | 5208.51 | 5310.40 | 5465.74 |
| Purchase of Traded Goods | 1653.85 | 1460.07 | 1427.04 | 1561.70 | 1211.23 |
| Increase/Decrease in Stocks | -120.73 | -245.03 | -352.60 | -660.65 | -285.52 |
| Employees Cost | 2506.13 | 2294.19 | 2181.43 | 2016.00 | 1906.94 |
| Depreciation | 834.89 | 862.96 | 786.46 | 777.60 | 744.06 |
| Other Expenses | 3788.11 | 3953.26 | 3713.00 | 3416.08 | 3216.95 |
| Total Expenses | 13707.21 | 13853.70 | 12963.84 | 12421.13 | 12259.40 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 2446.63 | 2506.94 | 2399.25 | 2510.80 | 1810.54 |
| Other Income | 225.50 | 292.10 | 356.93 | 283.86 | 273.52 |
| P/L Before Interest, Excpt. Items & Tax | 2672.13 | 2799.04 | 2756.18 | 2794.66 | 2084.06 |
| Interest | 192.99 | 233.50 | 223.74 | 164.98 | 124.73 |
| P/L Before Exceptional Items & Tax | 2479.14 | 2565.54 | 2532.44 | 2629.68 | 1959.33 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | -122.11 | -69.75 |
| P/L Before Tax | 2479.14 | 2565.54 | 2532.44 | 2507.57 | 1889.58 |
| Tax | 810.39 | 786.54 | 796.18 | 645.00 | 566.02 |
| P/L After Tax from Ordinary Activities | 1668.75 | 1779.00 | 1736.26 | 1862.57 | 1323.56 |
| Net Profit/Loss For the Period | 1668.75 | 1779.00 | 1736.26 | 1862.57 | 1323.56 |
| Minority Interest | 0.87 | 0.88 | 1.43 | -2.28 | 6.28 |
| Share Of P/L Of Associates | 3.58 | -30.60 | -1.09 | -15.25 | -1.91 |
| Net P/L After Minority Interest & Share Of Associates | 1673.20 | 1749.28 | 1736.60 | 1845.04 | 1327.93 |
| | | | | | |
| Equity Share Capital | 58.08 | 58.08 | 58.08 | 58.59 | 58.59 |
| Reserves And Surplus | 0.00 | 0.00 | 0.00 | 29784.21 | 0.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 28.81 | 30.63 | 29.69 | 31.79 | 22.57 |
| Diluted EPS (Rs.) | 28.81 | 30.63 | 29.69 | 31.79 | 22.57 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 28.81 | 30.63 | 29.69 | 31.79 | 22.57 |
| Diluted EPS (Rs.) | 28.81 | 30.12 | 29.69 | 31.49 | 22.57 |
| | | | | | |
| PBITOE Margin (%) | 15.14 | 15.32 | 15.61 | 16.81 | 12.86 |
| PBTE Margin (%) | 15.34 | 15.68 | 16.48 | 17.61 | 13.92 |
| PBT Margin (%) | 15.34 | 15.68 | 16.48 | 16.79 | 13.42 |
| PAT Margin (%) | 10.33 | 10.87 | 11.30 | 12.47 | 9.40 |
| PAT After MI And SOA Margin (%) | 10.35 | 10.69 | 11.30 | 12.35 | 9.43 |
